Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type 2 phosphatidylinositol-4,5-bisphosphate 4-phosphatase (PIP4P2) is a transmembrane enzyme localized to late endosome and lysosome membranes, where it catalyzes the removal of the 4-phosphate group from phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2), producing phosphatidylinositol-4-phosphate (PtdIns-4-P)[2][5][6]. It is specific for PI(4,5)P2, does not act on other phosphoinositide forms such as PI(3,4,5)P3 or PI(3,4)P2[2][5]. PIP4P2 negatively regulates phagocytosis and impacts cellular signaling by controlling levels of PI(4,5)P2, which is central to numerous processes, including cytoskeletal dynamics, membrane trafficking, and ion channel regulation[2][4][6]. Genetic variations are associated with inherited neurologic disorders such as spinocerebellar ataxia[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type 2 phosphatidylinositol-4,5-bisphosphate 4-phosphatase (PIP4P2).